HepNET Webinars

In this webinar, Dziko Singleton (she/her), a HepNET Leading with Lived Experience Consultant, is joined by Dr. Andrew Klein (he/him), volunteer at the Medical Reserve Corps and previously a physician at outpatient wound care centers to discuss the increasing presence of xylazine in the drug supply and its impact on people who use drugs. The panelists discuss how they are addressing xylazine’s health risks for people who use drugs in their respective care settings and share the latest findings, harm reduction strategies, and culturally responsive approaches to care that follow the lead of people directly impacted by xylazine use.

In case you missed it! Here’s the recording highlighting information about our 2023 Learning Community cohorts. This webinar features an overview of HepNET Learning Communities – the purpose to these cohorts, how they are structured, who’s involved, and how to apply to receive direct technical assistance in your jurisdiction, specific to hepatitis testing and linkage to care for people who inject drugs.

Additionally, check out the HepNET Frequently Asked Questions (FAQ). Please send all questions to hepatitis@nastad.org. NASTAD will continue to update questions for everyone to access.

NASTAD in partnership with National Viral Hepatitis Roundtable (NVHR) and National Association of County and City Health Officials (NACCHO) hosted the Hepatitis Network for Education and Testing (HepNET) Town Hall during Hepatitis Awareness Month. Check out the recording and slides to learn more about the structure of HepNET, who our primary partners are, and how you can become involved as a network member. We are working with state and local health departments (LHDs), tribal organizations, community-based organizations (CBOs), clinical providers, people with lived experience, syringe services programs (SSPs) and harm reduction programs to provide trainings and technical assistance to identify and address the unmet needs of people who inject drugs (PWID) and improve their access to viral hepatitis education, prevention, testing, linkage to care, and treatment.

During this webinar, NASTAD and its partners, NVHR and NACCHO, gave the spotlight to organizations that provide technical assistance (TA) related to offering and integrating hepatitis services for people who use drugs. Presenters from the American Association for the Treatment Opioid Dependence, AATOD, the National Harm Reduction Coalition, NHRC, and the Urban Survivors Union, USU speak to a variety of TA they provide, specifically for people with lived experience. This was followed by an open discussion for members to ask questions and learn how to access TA for their own organizations and glean insight on how this TA can help them identify and address the unmet needs of people who inject drugs (PWID) and improve their access to viral hepatitis education, prevention, testing, linkage to care, and treatment. 

Hep B United, NASTAD, and NVHR host a National Immunization Awareness Month webinar. Panelists discussed examples of successful community collaborations with Health Departments and how community organizations can form strong, lasting relationships with them in order to prevent hepatitis B.